Altered plasma protein binding of drugs in thyroid disease
- PMID: 7249488
- DOI: 10.2165/00003088-198106040-00004
Altered plasma protein binding of drugs in thyroid disease
Abstract
The plasma protein binding of propranolol and warfarin was studied in vitro by ultrafiltration in hyper- and hypothyroid patients both before and after treatment. The degree of binding of propranolol was significantly decreased in hyperthyroid patients and increased in hypothyroid patients, and was negatively correlated with serum thyroxine and the free thyroxine index. The plasma protein binding of warfarin was also decreased in hyperthyroid patients, but was unchanged in hypothyroid patients. These results suggest that the binding of both acidic and basic drugs may be altered by thyroid disease.
Similar articles
-
Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.Clin Pharmacokinet. 1987 Dec;13(6):345-64. doi: 10.2165/00003088-198713060-00001. Clin Pharmacokinet. 1987. PMID: 3325214 Review.
-
Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism.Br J Clin Pharmacol. 1978 Aug;6(2):123-7. doi: 10.1111/j.1365-2125.1978.tb00836.x. Br J Clin Pharmacol. 1978. PMID: 678388 Free PMC article.
-
Plasma propranolol steady state concentrations in thyroid disorders.Eur J Clin Pharmacol. 1981;19(5):329-33. doi: 10.1007/BF00544582. Eur J Clin Pharmacol. 1981. PMID: 7238561
-
Plasma cyclic AMP response to glucagon as an index of tissue responsiveness to thyroid hormone.Diabete Metab. 1978 Dec;4(4):267-70. Diabete Metab. 1978. PMID: 215472
-
Thyroid hormones and atrial natriuretic hormone secretion: study in hyper- and hypothyroid patients.Acta Endocrinol (Copenh). 1992 Jul;127(1):23-6. doi: 10.1530/acta.0.1270023. Acta Endocrinol (Copenh). 1992. PMID: 1387755
Cited by
-
Serum protein binding of propylthiouracil.Br J Clin Pharmacol. 1983 Nov;16(5):549-52. doi: 10.1111/j.1365-2125.1983.tb02214.x. Br J Clin Pharmacol. 1983. PMID: 6639841 Free PMC article.
-
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).Clin Pharmacokinet. 1990 Sep;19(3):218-29. doi: 10.2165/00003088-199019030-00005. Clin Pharmacokinet. 1990. PMID: 2203581 Review.
-
Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.Br J Clin Pharmacol. 1990 Nov;30(5):737-42. doi: 10.1111/j.1365-2125.1990.tb03844.x. Br J Clin Pharmacol. 1990. PMID: 2271373 Free PMC article.
-
Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.Clin Pharmacokinet. 1987 Dec;13(6):345-64. doi: 10.2165/00003088-198713060-00001. Clin Pharmacokinet. 1987. PMID: 3325214 Review.
-
Influence of thyroid dysfunction on drug pharmacokinetics.Clin Pharmacokinet. 1981 Jul-Aug;6(4):275-97. doi: 10.2165/00003088-198106040-00003. Clin Pharmacokinet. 1981. PMID: 6166422 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical